Similar Search Results

COVID-19 vaccines and the role of patents

Larson, Kelli - In: International journal of intellectual property … 11 (2021) 4, pp. 486-491

Persistent link: https://www.econbiz.de/10012800211

Cost-benefit analysis of the FDA : the case of the prescription drug user fee acts

Philipson, Tomas J.; Berndt, Ernst R.; Gottschalk, … - In: Journal of public economics 92 (2008) 5/6, pp. 1306-1325

Persistent link: https://www.econbiz.de/10003718171

Erstattungsbetragsverhandlungen bei innovativen Arzneimitteln aus Sicht des GKV-Spitzenverbandes

Stackelberg, Johann-Magnus von; Tebinka-Olbrich, Anja - In: Versorgungsdefizite im deutschen Gesundheitswesen : 18. …, (pp. 107-114). 2015

Persistent link: https://www.econbiz.de/10010478974

Assessing the safety and efficacy of the FDA : the case of the prescription drug user fee acts

Philipson, Tomas J.; Berndt, Ernst R.; Gottschalk, … - 2005

Persistent link: https://www.econbiz.de/10003193758

Do-it-Yourself Medicine? The Impact of Light Cannabis Liberalization on Prescription Drugs

Carrieri, Vincenzo - 2020

Governments worldwide are increasingly concerned about the booming CBD (cannabidiol) products. However, little is known about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using...

Persistent link: https://www.econbiz.de/10012839052